BioCentury
ARTICLE | Clinical News

FDA approves Symbiomix's Solosec for bacterial vaginosis

October 13, 2017 12:34 AM UTC

FDA approved an NDA from Symbiomix Therapeutics LLC (Newark, N.J.) for Solosec secnidazole to treat bacterial vaginosis...

BCIQ Company Profiles

Symbiomix Therapeutics LLC